Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB

New classes of antitubercular drugs, diarylquinolines and nitroimidazoles, have been associated with improved outcomes in the treatment of drug-resistant tuberculosis, but that success is threatened by emerging drug resistance. We report a case of bedaquiline and delamanid resistance in a 55-year-o...

Full description

Bibliographic Details
Main Authors: James Millard, Stephanie Rimmer, Camus Nimmo, Max O’Donnell
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2023-05-01
Series:Emerging Infectious Diseases
Subjects:
tuberculosis and other mycobacteria
bacteria
antimicrobial resistance
bedaquiline
delamanid
XDR TB
Online Access:https://wwwnc.cdc.gov/eid/article/29/5/22-1716_article

Similar Items

Similar Items